Iatrogenic botulism outbreak in egypt due to a counterfeit botulinum toxin a preparation–A descriptive series of patient features and outcome
EAMA Rashid, NM ElMahdy… - Basic & Clinical …, 2018 - Wiley Online Library
Iatrogenic botulism resulting from the substantial increase in use of botulinum neurotoxin
type A (Bo NTA) treatment is rarely reported. We aimed to describe a large iatrogenic …
type A (Bo NTA) treatment is rarely reported. We aimed to describe a large iatrogenic …
Iatrogenic botulism outbreak in Egypt due to a counterfeit botulinum toxin A preparation-a descriptive series of patient features and outcome.
E Rashid, NM El-Mahdy, HS Kharoub, AS Gouda… - 2018 - cabidigitallibrary.org
Iatrogenic botulism resulting from the substantial increase in use of botulinum neurotoxin
type A (BoNT-A) treatment is rarely reported. We aimed to describe a large iatrogenic …
type A (BoNT-A) treatment is rarely reported. We aimed to describe a large iatrogenic …
Iatrogenic Botulism Outbreak in Egypt due to a Counterfeit Botulinum Toxin A Preparation–A Descriptive Series of Patient Features and Outcome.
EAMA Rashid, NM ElMahdy… - Basic & Clinical …, 2018 - search.ebscohost.com
Iatrogenic botulism resulting from the substantial increase in use of botulinum neurotoxin
type A (BoNTA) treatment is rarely reported. We aimed to describe a large iatrogenic …
type A (BoNTA) treatment is rarely reported. We aimed to describe a large iatrogenic …
[引用][C] Iatrogenic Botulism Outbreak in Egypt due to a Counterfeit Botulinum Toxin A Preparation-A Descriptive Series of Patient Features and Outcome
EAMA Rashid, NM El-Mahdy, HS Kharoub… - Basic & Clinical …, 2018 - hal.science
Iatrogenic Botulism Outbreak in Egypt due to a Counterfeit Botulinum Toxin A Preparation - A
Descriptive Series of Patient Features and Outcome - Archive ouverte HAL Accéder …
Descriptive Series of Patient Features and Outcome - Archive ouverte HAL Accéder …
Iatrogenic Botulism Outbreak in Egypt due to a Counterfeit Botulinum Toxin A Preparation-A Descriptive Series of Patient Features and Outcome.
E Rashid, NM El-Mahdy, HS Kharoub… - Basic & Clinical …, 2018 - europepmc.org
Iatrogenic botulism resulting from the substantial increase in use of botulinum neurotoxin
type A (BoNT-A) treatment is rarely reported. We aimed to describe a large iatrogenic …
type A (BoNT-A) treatment is rarely reported. We aimed to describe a large iatrogenic …
Iatrogenic Botulism Outbreak in Egypt due to a Counterfeit Botulinum Toxin A Preparation-A Descriptive Series of Patient Features and Outcome
EAMA Rashid, NM El-Mahdy… - Basic & clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Iatrogenic botulism resulting from the substantial increase in use of botulinum neurotoxin
type A (BoNT-A) treatment is rarely reported. We aimed to describe a large iatrogenic …
type A (BoNT-A) treatment is rarely reported. We aimed to describe a large iatrogenic …